Nasdaq
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
NeuroOne Medical Technologies Corporation focuses on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) recording, spinal cord stimulation, brain stimulation, and ablation solutions. The company is based in Eden Prairie, Minnesota.
Roles derived from SEC Form 4 filings.
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | — | $178,146.00 | $171,169.00 | $2.0M | $3.5M | $9.1M |
| Gross profit | — | -$97,749.00 | -$70,794.00 | $456,517.00 | $1.1M | $5.1M |
| Operating income | -$4.9M | -$10.2M | -$10.0M | -$12.0M | -$11.9M | -$4.2M |
| Net income | -$13.6M | -$9.9M | -$10.0M | -$11.9M | -$12.3M | -$3.6M |
| Diluted EPS | — | -$0.93 | -$0.63 | -$0.65 | -$0.46 | -$0.09 |
| Operating cash flow | -$3.4M | -$8.6M | -$7.5M | -$12.9M | -$11.0M | -$2.8M |
| Free cash flow | -$3.5M | -$8.7M | -$7.8M | -$13.3M | -$11.1M | -$2.9M |
| Gross margin | — | -54.9% | -41.4% | 23.4% | 31.3% | 56.5% |
| Operating margin | — | -5735.9% | -5860.2% | -612.3% | -344.3% | -46.5% |
| Net margin | — | -5584.3% | -5842.0% | -607.4% | -356.7% | -39.6% |
| Line item | Q3 '24 | Q4 '24 | Q1 '24 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '25 | Q2 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $825,776.00 | $272,284.00 | $3.3M | $1.4M | $1.7M | $2.7M | $2.9M | $1.9M |
| Gross profit | $281,872.00 | $141,062.00 | $1.9M | $771,061.00 | $914,835.00 | $1.5M | $1.6M | $990,264.00 |
| Operating income | -$2.8M | -$2.8M | $1.7M | -$2.7M | -$1.9M | -$1.4M | -$1.7M | -$2.4M |
| Net income | -$2.8M | -$3.4M | $1.8M | -$2.3M | -$1.5M | -$1.6M | -$1.4M | -$2.4M |
| Diluted EPS | -$0.10 | -$0.11 | $0.06 | -$0.44 | -$0.03 | $0.32 | -$0.03 | -$0.28 |
| Operating cash flow | -$2.4M | -$2.7M | $208,049.00 | -$56,144.00 | -$1.5M | -$1.5M | -$3.1M | -$1.3M |
| Free cash flow | -$2.4M | -$2.7M | $183,633.00 | -$59,315.00 | -$1.5M | -$1.5M | -$3.2M | -$1.4M |
| Gross margin | 34.1% | 51.8% | 58.9% | 55.6% | 53.9% | 55.8% | 54.2% | 53.2% |
| Operating margin | -338.3% | -1034.5% | 52.3% | -193.3% | -111.2% | -50.0% | -59.0% | -128.7% |
| Net margin | -335.1% | -1230.6% | 54.5% | -163.8% | -88.5% | -59.1% | -49.7% | -127.9% |
Consensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-06-30 | Christianson Mark· Market Development Director | Sale | 10,000 | $3.18 | $31,773.00 | filing |
| 2026-04-03 | Mills Jason Richard | Award | 41,929 | $0.00 | $0.00 | filing |
| 2026-04-03 | MATHIESEN JEFFREY S | Award | 41,929 | $0.00 | $0.00 | filing |
| 2026-04-03 | BUCKMAN PAUL | Award | 41,929 | $0.00 | $0.00 | filing |
| 2026-04-03 | Andrle Edward | Award | 41,929 | $0.00 | $0.00 | filing |
| 2026-03-31 | Rosa David A· CEO and President | Tax withholding | 2,458 | $0.78 | $1,909.87 | filing |
| 2026-03-31 | Mertens Steve· Chief Technology Officer | Tax withholding | 906 | $0.78 | $703.96 | filing |
| 2026-03-31 | Christianson Mark· Business Development Director | Tax withholding | 253 | $0.78 | $196.58 | filing |
| 2026-03-30 | Christianson Mark· Business Development Director | Sale | 15,363 | $0.74 | $11,368.62 | filing |
| 2026-03-13 | Christianson Mark· Business Development Director | Sale | 100 | $0.80 | $80.00 | filing |
| 2026-03-12 | Christianson Mark· Business Development Director | Sale | 817 | $0.80 | $653.60 | filing |
| 2026-03-11 | Christianson Mark· Business Development Director | Sale | 2,109 | $0.80 | $1,687.20 | filing |
| 2026-03-10 | Christianson Mark· Business Development Director | Sale | 11,611 | $0.80 | $9,288.80 | filing |
| 2026-03-01 | Wambeke David J.· Chief Business Officer | Buy | 1,000,000 | $0.67 | $670,400.00 | filing |
| 2026-02-18 | Rosa David A· CEO and President | Tax withholding | 71,325 | $0.68 | $48,501.00 | filing |
| 2026-02-18 | Mertens Steve· Chief Technology Officer | Tax withholding | 7,376 | $0.68 | $5,015.68 | filing |
| 2026-02-18 | Christianson Mark· Business Development Director | Tax withholding | 1,812 | $0.68 | $1,232.16 | filing |
| 2025-12-31 | Rosa David A· CEO and President | Tax withholding | 2,458 | $0.76 | $1,863.16 | filing |
| 2025-12-31 | Mertens Steve· Chief Technology Officer | Tax withholding | 906 | $0.76 | $686.75 | filing |
| 2025-12-31 | Christianson Mark· Business Development Director | Tax withholding | 253 | $0.76 | $191.77 | filing |
| 2025-12-18 | Mills Jason Richard | Award | 7,758 | $0.00 | $0.00 | filing |
| 2025-09-30 | Rosa David A· CEO and President | Tax withholding | 2,458 | $0.89 | $2,184.18 | filing |
| 2025-09-30 | Mertens Steve· Chief Technology Officer | Tax withholding | 906 | $0.89 | $805.07 | filing |
| 2025-09-30 | Christianson Mark· Business Development Director | Tax withholding | 253 | $0.89 | $224.82 | filing |
| 2025-09-05 | Christianson Mark· Business Development Director | Sale | 30,000 | $0.74 | $22,203.00 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.